These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10637007)

  • 21. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A; Kessel D; Gomer CJ
    Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ; Ferrario A
    Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines.
    Nakamura H; Suzuki Y; Takeichi M; Saito T; Takayama M; Aizawa K
    Int J Gynecol Cancer; 2002; 12(2):177-86. PubMed ID: 11975677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response.
    McMahon KS; Wieman TJ; Moore PH; Fingar VH
    Cancer Res; 1994 Oct; 54(20):5374-9. PubMed ID: 7923168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic effect using a diode laser with mono-l-aspartyl chlorin e6 (NPe6) for implanted mouse tumor.
    Katsumi T; Kato H; Okunaka T; Kuroiwa Y; Yoshiteru I; Saito K; Konaka C; Aizawa K
    J Clin Laser Med Surg; 1994 Aug; 12(4):211-3. PubMed ID: 10147480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
    Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H
    Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photobleaching of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
    Spikes JD; Bommer JC
    Photochem Photobiol; 1993 Sep; 58(3):346-50. PubMed ID: 8234467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma.
    Matsumura H; Akimoto J; Haraoka J; Aizawa K
    Lasers Med Sci; 2008 Jul; 23(3):237-45. PubMed ID: 17703335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.
    Kato H; Furukawa K; Sato M; Okunaka T; Kusunoki Y; Kawahara M; Fukuoka M; Miyazawa T; Yana T; Matsui K; Shiraishi T; Horinouchi H
    Lung Cancer; 2003 Oct; 42(1):103-11. PubMed ID: 14512194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Threshold power levels for NPe6 photodynamic therapy.
    Kazi AA; Peyman GA; Unal M; Khoobehi B; Yoneya S; Mori K; Moshfeghi D; Moshfeghi AA
    Ophthalmic Surg Lasers; 2000; 31(2):136-42. PubMed ID: 10743925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dynamics of photosensitizer in the cell].
    Aizawa K; Kuroiwa Y; Tsuchida T; Xiahedin I; Shibuya H; Saito K
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):22-6. PubMed ID: 8546464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
    Harvey EH; Webber J; Kessel D; Fromm D
    Am J Surg; 2005 Mar; 189(3):302-5. PubMed ID: 15792755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy.
    Kasuya K; Shimazu M; Suzuki M; Kuroiwa Y; Usuda J; Itoi T; Tsuchida A; Aoki T
    J Hepatobiliary Pancreat Sci; 2010 May; 17(3):313-21. PubMed ID: 20464561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
    Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
    Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of photodynamic therapy using a fractionated dosing of mono-L-aspartyl chlorin e6 in a murine tumor.
    Webber J; Leeson B; Fromm D; Kessel D
    J Photochem Photobiol B; 2005 Feb; 78(2):135-40. PubMed ID: 15664500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
    Nakashizuka T; Mori K; Hayashi N; Anzail K; Kanail K; Yoneya S; Moshfeghi DM; Peyman GA
    Retina; 2001; 21(5):493-8. PubMed ID: 11642379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of the photosensitizer NPe6 following intravitreal injection.
    El-Dessouky ES; Moshfeghi AA; Peyman GA; Yoneya S; Mori K; Kazi AA; Moshfeghi DM
    Ophthalmic Surg Lasers; 2001; 32(4):316-21. PubMed ID: 11475398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sonodynamically-induced apoptosis, necrosis, and active oxygen generation by mono-l-aspartyl chlorin e6.
    Yumita N; Han QS; Kitazumi I; Umemura S
    Cancer Sci; 2008 Jan; 99(1):166-72. PubMed ID: 17970784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy.
    Nelson JS; Roberts WG; Berns MW
    Cancer Res; 1987 Sep; 47(17):4681-5. PubMed ID: 2957047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photosensitization with derivatives of chlorin p6.
    Kessel D; Woodburn K; Gomer CJ; Jagerovic N; Smith KM
    J Photochem Photobiol B; 1995 Apr; 28(1):13-8. PubMed ID: 7791001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.